We review recent advances regarding the pathogenesis of Huntington's disease (HD). This genetic neurodegenerative disorder is caused by an expanded CAG repeat in a gene coding for a protein, with unknown function, called huntingtin. There is selective death of striatal and cortical neurons. Both in patients and a transgenic mouse model of the disease, neuronal intranuclear inclusions, immunoreactive for huntingtin and ubiquitin, develop. Huntingtin interacts with the proteins GAPDH, HAP-1, HIP1, HIP2, and calmodulin, and a mutant huntingtin is specifically cleaved by the proapoptotic enzyme caspase 3. The pathogenetic mechanism is not known, but it is presumed that there is a toxic gain of function of the mutant huntingtin. Circumstantial evidence suggests that excitotoxicity, oxidative stress, impaired energy metabolism, and apoptosis play a role. 1999 Academic Press
INTRODUCTION
In 1872, George Huntington presented his classic paper describing the disease that later was to bear his name. Already in his description of families on Long Island affected by Huntington's disease (HD), he noted a typical pattern of inheritance. Although the early 20th century saw several publications on the genetics of HD, it was not until the development of modern molecular genetic techniques in the 1980s that major advances were made. The past 15 years have seen exciting progress that may help to unravel the pathogenesis of HD. The advances include the identification of the HD gene, characterization of the gene product huntingtin, and the discoveries of proteins associated with mutant huntingtin. In parallel, studies that have combined an increased understanding of the biology of cell death in the central nervous system and detailed knowledge of the neuropathology of HD have led to the creation of useful animal models of HD. Today research into the pathogenesis of HD stands at a very exciting crossroads, where the meeting between molecular genetics and neurobiology could yield a major breakthrough in the understanding of why particular groups of neurons gradually degenerate during the course of the disease. This progress will hopefully open new avenues for the development of novel therapies.
The main objectives of this review are to describe and collate crucial findings regarding possible pathogenetic mechanisms underlying HD (for earlier reviews see Refs. 1, 81, 103, 143, 157, and 162) . However, first we give a brief description of the epidemiology and clinical symptomatology of HD and describe neuropathological features of the disease. The main emphasis is then placed on the very rapid growth of knowledge that has taken place over the past 5 years regarding the disease mechanisms. A quantum leap in the knowledge about HD occurred in 1993 when the gene at fault was identified. As will be described in more detail in a later section, the HD gene contains an expanded sequence of the trinucleotide CAG and is inherited in an autosomal dominant pattern, with anticipation seen with paternal transmission (127) . It codes for a mutant form of a protein named huntingtin, whose normal function is unknown. In the concluding section of this review, we attempt to correlate several recent findings regarding the molecular pathology of HD and the neurobiology of cell death in one model of neurodegeneration in HD that encompasses distinct, yet related, cell death mechanisms such as excitotoxicity, impaired energy metabolism, oxidative stress, and apoptosis.
EPIDEMIOLOGY AND SYMPTOMATOLOGY
Huntington's disease affects all races and has the highest prevalence in Europe and North America, with 4-8 per 100,000 affected in Europe (72) . Males and females inherit the disease with equal frequency. The disease is characterized by symptoms affecting cognitive, emotional, and motor functions (for detailed description see Refs. 115 and 126) . Symptoms develop gradually and are initially very subtle and hard to differentiate from the patient's normal behavioral repertoire. Typically symptoms present between 35 and 45 years of age; however, as we elaborate upon later, disease onset can vary between childhood and old age, depending on the extent of the genetic defect. In adult onset HD, the disease always leads to death within 15-20 years of onset, usually following infectious complications of immobility. Juvenile cases often progress more rapidly and can typically lead to death within 7-10 years from disease onset. The cognitive disturbances usually begin with a slowing of intellectual processes and a reduced mental flexibility, finally leading to a full-blown dementia.
Emotional disturbances usually escort the loss of cognitive functions, with depression and manic-depressive behavior being common features. Personality changes, e.g., with irritability and apathy, also often accompany the psychiatric syndrome. Cognitive and emotional disturbances may appear less dramatic to the outsider than the motor symptoms described below; nonetheless, they are perhaps the most distressing features of the disease for the afflicted patient and family.
Disturbances in motor function are the classical feature of the disease and have led to use of the term Huntington's chorea (chorea, greek for dance). The impairment involves both voluntary and involuntary motor functions. The involuntary movements are choreatic, i.e., fast uncontrolled movements of limbs and distal muscles and involuntary movements of the proximal muscles of the trunk. The coordination of voluntary movements becomes progressively more difficult, finally being impossible. In juvenile onset HD, rigidity, tremor, and epileptic seizures are also frequent signs. Interestingly, there is often a marked loss of body weight in all patients with HD and a generalized lack of muscle bulk, despite increased calory intake (135) . It remains unclear whether this is the result of increased energy expenditure due to involuntary movements, a reduced gastrointestinal absorption, or whether there is a more complex underlying metabolic disturbance.
Both the absence of a satisfactory treatment for HD and the heredity result in enormous suffering for the affected person, and a heavy psychological strain for his or her relatives. This underscores the importance of research on the pathogenesis of HD and, ultimately, the possibility of finding a cure.
NEUROPATHOLOGY
In HD there is a selective neuronal loss in restricted regions of the brain. The most marked neuropathological features are the dramatic loss of neurons and the development of astrogliosis in the striatum (104) . The progressive changes result in a very marked atrophy and an approximately 60% reduction in the crosssectional area of the corpus striatum in advanced stages of the disease. Combined with a less-marked atrophy of the neocortex, this reduction in striatal volume leads to around 30% loss in the weight of the brain.
In the neostriatum, the GABAergic medium-sized spiny neurons, which constitute 95% of all striatal neurons, are the most affected. They are projection neurons that primarily innervate the substantia nigra and globus pallidus and contain also enkephalin, dynorphin, and substance P. There is relative sparing of medium-sized aspiny neurons that colocalize somatostatin, neuropeptide Y, and NADPH diaphorase, as well as of cholinergic interneurons and a subclass of GABAergic neurons that contain parvalbumin (88, 127) . Striatal neurons are divided into two compartments, patch and matrix, which have different biochemical features and connectivity (for review see Ref. 60) . In early stages of HD the neurodegeneration seems focused on the patch compartments (74) . However, in advanced HD there is a prominent loss of neurons in the matrix (53) , including neurons containing the Ca 2ϩ -binding protein calbindin 28K (141) . In the cerebral cortex, large neurons in layer VI are the most affected (73) . These neurons project primarly to the thalamus, claustrum, and other parts of the cerebral cortex. Therefore, it seems unlikely that the loss of neocortical neurons is simply explained by retrograde changes due to atrophy of the striatum, i.e., the target of the corticostriatal pathway. In addition to the striatal and cortical changes, the lateral tuberal nucleus of the hypothalamus exhibits atrophy (91) , and both amygdala and some thalamic nuclei display moderate atrophy.
Inspired by new neuropathological findings in a transgenic mouse model of HD (105) , as illustrated in Fig. 1 , there has been a recent surge of interest in the pathologic changes in the cell nuclei of neurons in patients with HD. These transgenic mice express exon 1 of a human HD gene that carries 115-156 CAG trinucleotide repeat expansions, as will be described in more detail later. They exhibit a progressive neurological phenotype that has some features reminiscent of HD, in particular the juvenile form of the human disorder. This behavioral phenotype includes motor symptomatology such as resting tremor, fast abrupt movements, and epileptic seizures (36) . Three of the existing mouse lines have been found to develop neuronal intranuclear inclusions that are prominent in neurons, but not glia, in the striatum (except interneurons), cortex, cerebellum, and spinal cord (36) . The neuronal intranuclear inclusions are immunoreactive for the N-terminal of huntingtin, which is the part encoded by exon 1 and ubiquitin, and appear prior to the development of the typical behavioral phenotype in the transgenic mice. Shortly thereafter, the nuclear membrane exhibits an increased number of indenta-tions and there is an apparent increase in the density of nuclear pores (36) . It is suggested that the transgenic fragment of huntingtin is transported to the nucleus, where it forms amyloid-like protein aggregates, analogous to scrapie prions and B-amyloid fibrils in Alzheimer's disease (137) . These findings in the transgenic mouse model of HD prompted a search for similar changes in human HD (36) . Interestingly, relatively old literature (131) revealed that striatal biopsies from HD patients display nuclear inclusions with an ultrastructural appearance similar to the inclusions seen in the transgenic HD mice. Furthermore, other reports have described an increase in nuclear membrane indentations (22) and the density of nuclear pores (150) in striatal biopsies from HD patients. The correlation between these findings in the mouse model and the human disorder stimulated a detailed immunocytochemical mapping of the neuronal intranuclear inclusions found in the cortex and the striatum of HD patients (19, 44) . The inclusions contain NH 2 terminal fragments of the mutant huntingtin which is ubiquitinated. One spherical inclusion per nucleus is most common and they are detected in all cortical layers, with the highest frequency in juvenile forms of HD. Similar fragments of huntingtin are also found in dystrophic neurites of neurons predominantly in cortical layers V and VI. In contrast to the intranuclear inclusions, the dystrophic neurites are more prevalent in adult onset HD. These differences between juvenile and adult onset HD pathology may account for the distinctly different clinical phenotypes of these two groups. Thus, these novel ultrastructural findings regarding the detailed pathology of HD may provide important clues for the pathogenesis of the disease, although they may only constitute markers for neurodegeneration and perhaps are not primarily involved in the disease process. Moreover, the functional role of the part of huntingtin encoded by exon 1 is also not clear. During 1998 there appeared preliminary reports of several other interesting transgenic HD mouse models. These mice are likely to provide valuable contributions to research on the pathogenesis of HD. Hayden and co-workers have produced a YAC transgenic mouse expressing normal (18 CAG repeats) and mutant (46 CAG repeats) human huntingtin (75) . There is no behavioral phenotype nor any neuronal loss in this mouse, nevertheless long-term potentiation is reduced in hippocampal slices from the mouse expressing the mutant huntingtin. In another transgenic mouse produced by Aronin and collaborators, the transgene encodes the first third of the huntingtin cDNA sequence with CAG repeat lengths of either 46 or 100 (94) . These mice exhibit cortical and striatal neuronal inclusions as well as a behavioral phenotype with hyperactivity (94, 31) . Another group has produced mice with 71 and 94 CAG repeats that do not contain any nuclear inclusions or show any behavioral deficits, but display an enhanced sensitivity to glutamate receptor activation in striatal neurons (96) .
MODELS OF NEURONAL CELL LOSS IN HUNTINGTON'S DISEASE
Many different experimental models of neurodegeneration have been suggested to be relevant to HD (13, 34, 65) . Excitotoxicity and oxidative stress are two conditions leading to cell death that are thought to be important in several neurodegenerative diseases (35) . Both these processes can be part of a vicious cycle in which they are initiated by, or themselves contribute to, an impairment in mitochondrial function, eventually resulting in energy failure of the cell (15, 17) . Over recent years, increasing attention has been paid to apoptosis as a path to cell death in neurodegenerative diseases and it has been suggested to be of direct importance in the striatal cell loss seen in HD (124) . Again it is possible that the apoptotic pathway interacts with the three mechanisms just mentioned. Thus, although several mechanisms may cooperate in bringing about neuronal death in HD, for clarity we have divided this section into four parts, namely, excitotoxicity, oxidative stress, impaired energy metabolism, and apoptosis.
Excitotoxicity
The expression excitotoxicity was coined in 1969 as a description of the neurotoxic effect of excitatory amino acids, which destroy the neurons at the site of injection (122) . Excitotoxicity may play a major role in the pathogenesis of HD (Fig. 2) . The first observations linking excitotoxicity to HD appeared in 1976, when it was noted that intrastriatal injections of kainic acid, an agonist of the kainate/quisqualate subclass of glutamate receptors, can produce lesions similar to those seen in HD (34, 109) . At the site of injection, the striatum is depleted from neurons, while afferent fibers, nonneuronal components, and the large striatal interneurons are spared. This led to the suggestion that glutamate plays a central role in HD pathogenesis. Several different classes of glutamate receptors have been identified and they are divided into ionotropic receptors controlling ion channels and metabotropic receptors coupled to G-proteins. The ionotropic receptors are (i) N-methyl-D-aspartate (NMDA)-receptor, sensitive to NMDA and quinolinic acid, (ii) ␣-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor, sensitive to AMPA and kainic acid, and (iii) kainic acid (quisqualate) receptor, sensitive to kainic acid and quisqualic acid (46, 101) . Upon activation, the NMDA receptor channel becomes permeable to Ca 2ϩ and Na ϩ . Metabotropic receptors are thought to enhance NMDAreceptor-mediated Ca 2ϩ entry through phospholipasecoupled protein kinase C activation (138) . Intrastriatal injections of quinolinic acid, which is a NMDA receptor agonist, produce lesions even more similar to the HD neuropathology, selectively affecting the striatal projection neurons (13, 14, 78) . In contrast to kainic acid, quinolinic acid is an endogenous brain metabolite. Quinolinic acid selectively spares striatal interneurons containing somatostatin, neuropeptide Y (14) , and NADPH diaphorase (86) . It is less likely that AMPA or kainate receptors play an important role in the presumed excitotoxicity in HD, as experimental lesions with kainic acid and AMPA affect all cell types without any sparing of somatostatin/neuropeptide Y/NADPH diaphorase neurons in the striatum (13, 14) . Furthermore, following quinolinic acid injections into the rat striatum, the patch compartment is spared while the neurons in the matrix compartment die. Indeed, there is primarily degeneration of the medium-sized GABAergic spiny efferent neurons projecting from the striatum to the globus pallidus and pars reticulata of the substantia nigra (14) . These results, in addition to the observation that NMDA receptors are depleted in HD striatum (165) , suggest that NMDA-receptor-mediated excitotoxicity has a role in HD and that experimental quinolinic acid lesions in animals can serve as a model of HD. Nonetheless, the distribution of the neuronal loss in HD does not closely correlate to the density of NMDA receptors in brain (113, 159) . For example, NMDA receptors are equally present in striatum and hippocampus. While HD kills striatal neurons, it leaves the hippocampus unaffected. Furthermore, NMDA receptors in the cortex are most prominent in the superficial layers, while HD depletes neurons primarily in cortical layers V and VI. In the lateral tuberal nucleus of the hypothalamus, there is a correlation between the presence of NMDA receptors and the occurrence of neuronal death in HD (90) . As the lateral tuberal nucleus may participate in appetite control in humans, this lesion could play a role in the weight loss commonly seen in HD patients (92) .
Excitotoxicity could also be due to a reduced uptake of glutamate by the glial cells. So far, four different glutamate transporters have been identified: the glutamate-aspartate transporter, glutamate transporter 1 (GLT1), excitatory amino acid carrier 1, and excitatory amino acid transporter 4 (58) . It has been proposed that defective glutamate transporters are important components in neurodegenerative diseases (66) , and it has been shown that there is a reduced GLT1 mRNA expression in glial cells in putamen in HD brains and an increased number of GLT1 containing cells in the whole striatum due to astrogliosis (9) . How this is connected to the initiation or progression of the disease is not clear; however, a role of glial cells in the pathogenesis of HD cannot be ruled out.
Oxidative Stress
Oxidative free radicals, i.e., highly reactive oxygen derivates with an unpaired electron in the outer shell, are toxic to cells. When present in excess they give rise to a situation named oxidative stress (47) . This may, for example, be the consequence of mitochondrial malfunction (139) or excitotoxicity (18) and can probably trigger apoptosis under certain conditions (Fig. 3 ). An increase in intracellular Ca 2ϩ can activate phospholipase A 2 (PLA 2 ) and Ca 2ϩ -dependent proteases. PLA 2 activity results in increased production of arachidonic acid, and the subsequent metabolism of arachidonic acid can induce formation of free radicals. Hydrogen peroxides and superoxides are formed through the activation of Ca 2ϩ dependent proteases, and hydrogen peroxide can be converted to hydroxyl radicals, thereby contributing to neurotoxicity. This conversion is favored by the presence of Fe 2ϩ ions. Recent reports indicate that administration of spin-trap agents, which reduce oxidative stress, can ameliorate striatal damage induced by an intrastriatal injection of quinolinic acid (116, 117, 139) . Thus, they provide further indirect evidence for the involvement of free radicals in excitotoxic cell death.
Nitric oxide (NO) can also act as a toxic free radical. It is the result of neural nitric oxide synthase (nNOS) activity and is a mediator of NMDA toxicity in cell cultures (39) . An increase in the cytosolic concentration of Ca 2ϩ through entry via NMDA channels triggers Ca 2ϩ /calmodulin binding, in turn activating the phosphatase calcineurin that, finally, activates nNOS. It has been shown that nNOS gene null mice are resistent to excitotoxicity (40) ; however, there is also evidence of a protective effect of NO against excitotoxicity, through regulation of NMDA receptors (7, 107) . In this context it is important to point out that striatal nNOS-positive neurons, identical to those containing neuropeptide Y and somatostatin, are spared during HD (25, 38, 77) . One possible reason for this sparing is that nNOS neurons express high levels of manganese superoxide dismutase (62) , and overexpression of this enzyme has been shown to protect cortical neurons in vitro from NMDA and NO toxicity, but not from AMPA-or kainateinduced damage (62) . In short, the precise role of NO in HD remains unclear.
Impaired Energy Metabolism
Impaired energy metabolism reduces the threshold for glutamate toxicity (121) and can lead to activation of excitotoxic mechanisms (15) as well as an increased production of reactive oxygen species (35) , as illustrated in Fig. 4 . Energy depletion can result in partial depolarization of the outer membrane and thereby release the voltage dependent Mg 2ϩ ion block of the Ca 2ϩ channel in the NMDA receptor complex. When this inhibition has been removed, Ca 2ϩ enters the cell more readily after stimulation by glutamate, resulting in the excitotoxic cascade that involves oxidative stress and is described above. Sodium ions can also enter through the NMDA channel, and under conditions of energy deprivation they will be less effectively extruded from the cytoplasm by the energy-dependent Na ϩ /K ϩ Ϫ ATPase. As a result, intracellular Na ϩ levels rise and reduce the efficacy of the Na ϩ -Ca 2ϩ antiport system that normally exports Ca 2ϩ to the outside. Impaired mitochondrial function can also directly affect intracellular Ca 2ϩ concentration, since the mitochondrion normally is the most important organelle for Ca 2ϩ seques-
FIG. 3.
Oxidative stress is the excessive production of free radicals, leading to cell death by either apoptosis or necrosis.
tration. A reduced ability of mitochondria to maintain a proton gradient and negative potential on the inside of the inner membrane will reduce their capacity to attract positively charged Ca 2ϩ . In summary, reduced energy production can lead to severe neuronal injury in a multitude of ways.
The idea that HD could be related to a specific mitochondrial malfunction is not farfetched since there are a number of neurodegenerative diseases with mitochondrial mutations that display pathology in the CNS. They include Leber's optic atrophy, mitochondrial encephalopathy with lactic acidosis and stroke-like symptoms, and myoclonic epilepsy ragged red fiber disease (17, 45) . Mitochondrial heterogeneity due to tissuespecific isoenzyme forms of respiratory chain complexes may explain why in most cases only cells in specific tissues die. Although HD is the result of a mutation in nuclear and not mitochondrial DNA, it is still possible that huntingtin normally participates in the regulation of mitochondrial function or that the mutant form actively interferes with cellular respiration.
Metabolic changes have been observed in the brains of HD patients, using nuclear magnetic resonance spectroscopy (80) . There is a hypometabolism of glucose in cortex and striatum in early HD, and elevated lactate levels have been observed in the basal ganglia and the occipital cortex of patients. There is also an elevated lactate-pyruvate ratio in the cerebrospinal fluid of HD patients (80, 93) . Biochemically, there is evidence of impaired mitochondrial function in HD caudate neurons. Gu and co-workers (66) observed a distinct reduction of the respiratory chain complex II and III activity, and a mild change of the complex IV activity, of mitochondria of caudate neurons in HD patients, while these changes were absent in platelet mitochondria. The extents of complex II and complex III deficiency were correlated. This suggests that there may be a deficiency of ubiquinone, which is an electron carrier used by both complexes (66) .
These observations are consistent with experiments on administration of 3-nitroproprionic acid (3-NP) to rat striatum (2) . The toxin 3-NP irreversibly inhibits succinate dehydrogenase, which is complex II of the respiratory chain. In rats, intrastriatal administration of 3-NP caused a dose-dependent ATP depletion and increased lactate concentration and neuronal loss in the striatum (16) . The neuronal loss was ameliorated if the rats were decorticated before 3-NP administration, implicating an important role for the glutamatergic input via the corticostriatal pathway in the observed neurotoxicity of 3-NP (16) . Antagonists of excitotoxic amino acids also block the neurotoxic effect of 3-NP, indicating that impaired energy metabolism, through the mechanisms described above, might predispose cells to excitotoxicity (16) . Systemic injections of 3-NP into rats have been shown to produce a selective loss of medium spiny neurons in striatum (65) , suggesting that the neuronal population that is most affected in HD is particularly sensitive to energy impairment.
In humans, 3-NP induces nausea, vomiting, encephalopathy, coma, and, when the subject survives, there are choreiform movements and dystonia (102) . The facts that complex II inactivation by itself can induce the same type of pathology as seen in HD, and observations of a reduced complex II, III, and IV activity (66) , all strengthen the hypothesis that the defect HD gene product could alter mitochondrial complex II to IV or ubiquinone function indirectly, possibly by changing mitochondrial protein import or mitochondrial membrane structure or function.
Apoptosis
Apoptosis is normally activated in the nervous system during embryogenesis when programmed cell death is necessary to remove supernumerary neurons as part of natural development. However, apoptosis has also been suggested to be involved in several pathological conditions in the brain (42, 95) . This type of cell death first described by Kerr and co-workers in 1972 (85) , is morphologically characterized by membrane blebbing, perinuclear chromatin condensation, swelling of the organelles, and endonuclease-mediated internucleosomal DNA fragmentation (24, 164) . The DNA is fragmented in a nonrandom pattern, producing a ladderlike formation in agarose gel electrophoresis. In contrast, necrotic cell death is characterized by vacuolated cells with swollen and lysed organelles, condensed chromatin appearing in multiple small aggregates around the periphery of the nucleus, degradation of histones, and random degradation of DNA, resulting in a DNA smear on agarose gel electrophoresis. In a study of cerebellar granular cells, Ankarcrona and co-workers (6) showed that the mode of excitotoxic cell death following exposure to glutamate can depend on the status of the mitochondria. Relatively intact mitochondrial function was necessary for apoptosis to occur. A lack of mitochondrial membrane potential was consistent with necrosis. However, other studies have indicated that impairment of mitochondrial function due to selective inhibition of the different respiratory chain complexes can cause apoptosis (20, 110, 140) . As described earlier, stimulation by glutamate receptors leads to Ca 2ϩ influx through open NMDA channels. Eventually, the Ca 2ϩ accumulates in excess in the mitochondria. The mitochondrial inner membrane potential is transiently depolarized, giving rise to a mitochondrial permeability transition (PT) (167) . It involves the fusion of inner and outer mitochondrial membrane proteins, forming the mitochondrial PT pore complex. The induction of such pores is also stimulated by increased production of reactive oxygen species (145) . Upon the collapse of the inner membrane potential, cytochrome C and a protein named apoptosisinducing factor (AIF) are thought to be released through the pores (148, 95, 152) . Cell death can be blocked by an antagonist of interleukin-1␤-converting enzymes (148) , suggesting that AIF is related to an interleukin-1␤-converting enzyme and thus part of a family of proapoptotic cysteine proteases (caspases) initially described in the nematode Caennorhabditis elegans (166) . In short, it is evident that oxidative stress and excitotoxicity, and thereby also partial energy failure, can lead to apoptosis (Fig. 5) , rendering the study of programmed cell death in HD very relevant.
Using the terminal transferase-mediated deoxyuridine triphosphate-biotin nick-end labeling (TUNEL) method to detect DNA strand breaks in apoptotic cells, Portera-Cailliau and colleagues (124) showed that a subset of neurons and glia in the neostriatum of HD patients appears to undergo apoptosis. Isolated medium spiny neurons were stained, most intensely in the putamen, followed by the globus pallidus and caudate. Labeling was also increased in more advanced cases of the disease. However, even in these advanced cases only a small fraction of the cells was labeled with TUNEL. Possibly, fragmenteded DNA was present below the limit of detection in a larger number of cells or the low frequency of labeling reflects the slow development of the disease (124) . Findings from other studies also employing the TUNEL technique support the idea that apoptosis occurs in HD (49, 151) , and it has also been shown that there is positive correlation between the number of CAG repeats in HD and the degree of nuclear fragmentation in the HD striatum using DNA fragmentation assays (27) . However, it is important to notice that the DNA damage assessed by TUNEL is not completely specific for apoptosis, and clear morphological evidence for an apoptotic process in HD is still missing (120) .
GENETICS IN HUNTINGTON'S DISEASE
As briefly mentioned in the introduction, HD is caused by an expanded, unstable trinucleotide repeat in a gene of unknown function. The HD locus was one of the first disease-associated loci to be discovered with the help of restriction-fragment length polymorphism, and the gene was localized to chromosome 4 in 1983 (67) . By using haplotype linkage analysis the genetic defect was located to 4p16.3, and by linkage disequilibrium the gene was more precisely mapped. After 10 years of further research, the gene for ''the interesting transcript 15'' (IT15) was identified in 1993 (79) . It was found to contain a polymorphic trinucleotide repeat that was expanded and unstable in HD patients. The repeated trinucleotides contain the bases cytosine, adenine and guanine (CAG), encoding the amino acid glutamine. The CAG repeat is located within the coding sequence, 17 codons downstream of the initiator ATG in exon 1 of the 67 exon gene (3). It is translated and transcribed with the rest of the gene, hence giving rise to a polyglutamine array in the IT15 gene product, which is a protein that has been given the name huntingtin (79) .
In normal subjects, the gene contains about 9-34 CAG repeats in the region affected in HD patients (146) , while the presence of 37 or more CAG repeats gives rise to HD (10, 68) . However, some persons with 37-39 repeats are clinically unaffected, indicating a reduced penetrance for HD among individuals with repeat lengths exceeding the critical threshold (111) . There is an inverse correlation between the number of CAG repeats and the age of onset (23, 153) . A repeat length of 40-50 is most frequently seen when the onset of the disease occurs in mid-life, while longer repeats,
FIG. 5.
Apoptosis can be the consequence of excitotoxicity and oxidative stress. Cytochrome C (Cyt C) and apoptosis-inducing factor (AIF) have been proposed to be released from mitochondria upon collapse of the inner membrane potential (148, 95, 152) . sometimes above 100, cause juvenile-onset HD. For cases with 37-50 repeats it is difficult to precisely predict the age of onset, whereas for individuals with more than 50 repeats there is a clear correlation: The higher the number of repeats, the earlier the onset of symptoms. In correlation analyses, the CAG repeat number only explains 50% of the variance in age of onset (127) , and it has been speculated that ''aging genes'' inherited from the unaffected parent (51) also are involved in determining the age of onset. Recently genetic polymorphisms adjacent to the CAG repeat have been suggested to influence the age of onset in HD patients in a recent study (158) . There are also reports suggesting that the speed of progression of disease is correlated to the number of CAG repeats (23, 146) , but this observation has not been substantiated by others (32) .
Other Triplet Repeat Diseases
There are several different genetic diseases besides HD that have been identified as unstable triple repeat diseases (114) . The severity and age of onset in all of them are correlated to the repeat length, although other factors also play a role. All these diseases also exhibit a pattern of anticipation as will be described for HD in a later section on instability of CAG repeats. The triplet repeat diseases can be divided into two groups. One includes fragile X, myotonic dystrophy, and Friedrich's ataxia and exhibits repeats in a noncoding sequence of the DNA genome (81) . The other group includes diseases like HD which have expanded CAG repeats in the genome, resulting in a polyglutamine tract. The latter group consists of spinobulbar muscular atrophy (SBMA), dentatorubral pallidoluysian atrophy (DRPLA), and spinocerebellar ataxia (SCA) 1, 2, 3, 6 and 7 (70) .
These disorders result in a selective loss of neurons, but with a different anatomical distribution in each disease (133) . Intranuclear inclusions are seen in HD (44), DRPLA (19) , and SCA 3 (123) . In SCA 3 the disease protein ataxin-3 accumulates in ubiquitinated intranuclear inclusions in affected brain regions. It is possible that these disorders are due to a similar polyglutamine-dependent gain of function of the proteins involved, with neuronal intranuclear inclusions as part of the common pathogenetic mechanism (37, 134) . This may mean that understanding the exact pathogenesis of one of these diseases could provide valuable information about the others.
Toxic ''Gain of Function''
Several important observations suggest that the HD mutation causes a simple toxic ''gain-of-function.'' First, there are mRNA transcripts from both the normal and the expanded allele of the IT15 gene in lymphoblasts and the brain (3). Second, there is no indication that patients homozygotic for mutated IT15 develop the disease earlier or exhibit faster progression (163) , implying that the existence of normal gene copies is not important. Third, homozygotes have been shown to express mRNA for an expanded IT15 gene and it does not seem that the expanded CAG repeat causes inactivation of the gene (79) . Fourth, in rare genetic mutations, individuals with one deleted IT15 gene have been identified and they do not exhibit any symptoms of HD. Clearly, it is important to understand why huntingtin acquires toxic properties when the number of repeats reaches 37 or more and how huntingtin interacts with other cellular proteins. By understanding these mechanisms it may be possible to intervene in the process leading to neural cell death in the striatum. Therefore, the remaining sections of this review are largely devoted to these issues.
Instability of CAG Repeat Number
The inheritance of HD is with genetic anticipation. There is younger age of onset in successive generations within a pedigree. The anticipation in HD is seen in paternal transmission (127) , which indicates the large number of mitotitic divisions in spermatogenesis could be responsible for the instability of repeats (68) . However, the molecular mechanisms underlying repeat expansion in HD are not clear. It has been suggested that replication errors such as replication slippage or gene conversion can take place (114) . In a recent study (106) , no instability was observed in the offspring from a HD transgenic male mouse whose transgene was not expressed, while in mice that expressed the transgene there was an expansion of CAG repeats analogous to that observed in human HD. This implies that repeat instability is related to gene transcription. In paternal HD transmission, long expanded repeats (46 or more) also show a greater tendency for further expansion than do short repeats (127) . Maternal repeats typically exhibit no mean change in repeat length during transmission (127) . Consequently, offspring from affected fathers have on average both longer CAG repeats and earlier ages of onset than offspring from affected mothers with the same repeat length (5). Genetic anticipation in HD is thus a phenomenon of paternal transmission. In rare cases, contraction of the repeat length has also been observed following paternal transmission (127) .
Interestingly, studies on the transgenic HD mouse have revealed a correlation between the age of the transgenic male mouse and the CAG repeat size of the offspring (106) . This correlation is also seen with HD patients (52, 89) . Furthermore, there is a certain degree of tissue mosaicism regarding CAG repeat numbers in HD patients (8) , with the greatest variance of repeats numbers typically found in neurons and sperm (149) . In the brain, the regions most affected in HD, cortex and striatum, also display the largest mosaicism, whereas cerebellum, which is relatively spared, has the lowest level of mosaicism. In two cases of very early juvenile HD, there was a difference of 8-13 CAG triplets between cells in the cerebellum and other brain regions, the cerebellar neurons having the lower number of CAG repeats (149) . Evidently there is a CAG repeat instability in somatic tissues in affected individuals, but it is not exclusive for regions displaying selective neuronal loss, and the underlying mechanism for the instability somatic cells also remains obscure. Notably, the HD transgenic mouse developed by Bates and coworkers also exhibits a degree of tissue mosaicism and repeat instability in somatic cells (106) . Thus, in many respects this HD transgenic mouse provides a valuable model for the study of genetic mechanisms in HD.
Expression of the IT15 Gene
The mRNA of the IT15 gene is normally expressed in all tissues of the body (147, 154) , and, as mentioned earlier, the expression of the mRNA (147) and the protein (63) is not changed in HD. In the brain, expression of IT15 is mainly neuronal, with only low levels in glia (98, 142) . The regional pattern of expression correlates to neuronal density. Therefore cerebellum, hippocampus, and olfactory bulb display the highest IT15 expression. Consequently, the striatum expresses low to intermediate levels of IT15 mRNA. Thus, the selective neuropathology seen in HD, which is focused on the striatum, cannot be simply explained by regional variations in HD gene expression. It has been suggested that there is a striatal dopamine D1 and D2 receptor loss in asymptomatic mutation carriers of HD and that dopamine receptor binding could be a sensitive means of detecting subclinical striatal dysfunction (161) . Similar findings of reduced dopamine receptor densities have been observed in mice transgenic for exon 1 of the HD gene (30) . Also, with increasing pathology, the number of D2-positive striatal neurons decreases in HD patients. In contrast, despite a decrease in D1 positive neurons, the cellular expression of D1 mRNA at the single cell level actually increases with progressive pathology, possibly reflecting a relative survival of D1-expressing striatal interneurons (11) . It was recently demonstrated that there is a heterogenous distribution of huntingtin within the neurons of the normal human striatum (54) . Huntingtin immunoreactivity is primarily seen in the matrix region, with only little staining in the patch regions. As previously mentioned, there is major loss of calbindinpositive neurons in the matrix (141) and recent work has demonstrated a correspondence between the presence of calbindin and huntingtin, with only very little coexpression of huntingtin and NADPH-diaphorase and nitric oxide synthase (54) . This suggest that the selective vulnerability of medium-sized spiny neurons in the matrix compartment of the striatum is due to higher levels of huntingtin expression, while the relative resistance of large and medium-sized aspiny neurons in the patch compartments is associated to lower levels of huntingtin.
Huntingtin-Protein Characteristics
Huntingtin is a protein with around 3140 amino acids, depending on the number of CAG repeats, and with a mass of approximately 349 kDa (79) . The amino acid sequence of huntingtin has no major homology with any known protein. The segment with the glutamine repeat starts at residue 18 and there is also a polymorphic CCG repeat encoded polyproline region. The protein has no hydrophobic membrane-spanning regions. It has a motif called the ''HEAT repeat,'' named after the four functional proteins in which the repeat has been detected. They are huntingtin, elongation factor 3, the regulatory A subunit of protein phosphatase 2A, and TOR 1 (4). The HEAT repeat consists of two hydrophobic ␣-helices and it has been suggested that they are important for protein-protein interactions. These proteins are regulatory cytoplasmic proteins and are involved in cytoplasmic transport processes. As elaborated upon below, it has been suggested that huntingtin is involved in vesicle trafficking.
Intracellular Localization of Huntingtin
The intracellular localization of huntingtin is still somewhat controversial. Hoogeveen and collaborators demonstrated in 1993 (76) , in an immunohistochemical study using antisera directed to the C-terminus of huntingtin, that huntingtin is localized to both the nucleus and the cytoplasm in neurons from HD patients. In contrast, in peripheral organ tissues it was only localized to the cytoplasm. DiFiglia and coworkers showed in 1995 (43), also using immunocytochemistry, that in human brain huntingtin is present in the cytoplasm of neuronal somata, dendrites, and axons. More recent findings demonstrate the mutant huntingtin is only present in neuronal perikarya and proximal nerve processes but not in nerve endings (63) . This suggests abnormal expression or processing of mutant huntingtin at these sites. Using sucrose density gradients, DiFiglia's group (43) revealed that huntingtin is found in vesicle-enriched fractions, where huntingtin immunoreactivity overlaps with the distribution of vesicle membrane proteins like the transferrin receptor and synaptophysin. It has also been demonstrated that huntingtin is associated with cytoplasmic granules, resembling multivesicular bodies, organelles involved in retrograde transport and protein degradation, in some HD cortical and striatal neurons (136) . In addi-tion, other studies indicate that huntingtin associates with microtubuli (69, 155) , indicating that huntingtin may have a function in vesicle trafficking. Further support for this concept is provided by findings showing that both mutant and normal huntingtin associates with clathrin-coated vesicles in the Golgi network, cytoplasm, and the plasma membrane (156) . In another study huntingtin was found in both the cytoplasm and in the nucleus in different mammalian cellines (41) . Importantly, DiFiglia and collaborators recently used electron microscopy to demonstrate that in HD patients there is an NH 2 -terminal fragment of mutant huntingtin in neuronal intranuclear inclusions and in dystrophic neurites (44) .
Normal Function of Huntingtin
The absence of major homology between huntingtin and other proteins means that we are left with very few cues as to its normal function. From studies on cloned IT15 homologues in mouse, rat, and pufferfish the gene seems highly conserved through evolution (143) . This high degree of preservation suggests that huntingtin may normally have an important cellular function. Interestingly, one of the less conserved regions contains the CAG repeat, and while normal huntingtin in humans contains 8-36 glutamines, mouse, rat, and pufferfish genes encode only 7, 8, and 4 glutamines, respectively. This could imply that the region carrying the CAG repeat is likely to be unimportant for the normal function of huntingtin; however, this does not seem to be the case.
To examine the normal function of huntingtin, three studies have focused on targeted disruption of the homologous gene in mice (Hdh). The studies have used different approaches, targeting disruptions in exon 5 (118), exon 4 (48), and the promoter region (168) . All their experiments showed that the protein is functionally indispensable because nullizygous embryos were developmentally retarded and died in utero. In the null mutants, the level of the regionalized apoptotic cell death in the Hdh-expressing embryonic ectoderm was strikingly higher than normal. More recently, Hayden and co-workers have produced a mouse using a cell-typerestricted inactivation of huntingtin at later developmental stages (112) , thereby preventing the early embryonic mortality seen in mice nullizygous for the HD gene homologue (168) . This model may promote understanding of the normal function of huntingtin in the striatum and other tissues.
Altered Properties of Mutant Huntingtin
Theoretically there are many different ways an expanded number of CAG repeats in the HD gene could affect huntingtin function. The polyglutamine could increase the normal activity of huntingtin. Alternatively, the polyglutamine could act in a dominant negative fashion, eliminating the normal function of huntingtin and in turn also affecting huntingtin transcribed from the normal alleles. Finally, it seems plausible that the polyglutamine stretch endows huntingtin, by a ''gain of function,'' with properties that permit new protein interactions. Two recent series of papers propose specific functions for mutant huntingtin that can result in cell death.
First, it is known that polyglutamine sequences are capable of linking ␤-strands together into barrels or sheets by hydrogen bonding, forming so-called polar zipper structures (125) . Possibly ␤-sheets formed by the polyglutamine stretch could cause huntingtin to aggregate and thereby interfere with vital cellular processes (97) . The presumed normal function of polar zippers is to join specific transcription factors bound to separate DNA sequences, as, for example, is seen with leucine zippers that can join the transcription factors Jun and Fos. Indeed, many transcription factors contain glutamine-rich activation domains and there is a correlation between transcriptional activity and the glutamine stretches up to a length of 40 (59) . Greater numbers of glutamine residues actually result in a reduced transcriptional activity. This suggests that if huntingtin normally functions as a transcription factor, its activity may be reduced when the number of glutamines exceeds 37.
Second, aggregation of mutant huntingtin products could also be a consequence of the action of transglutaminases, enzymes normally involved in crosslinking of glutamine residues in different proteins (55) . Transglutaminases are known to function in differentiating tissues in neural development (71) and display increased activity after injury in the adult spinal cord (56) . As an expanded polyglutamine stretch could result in increased cross-linking between mutant huntingtin products, this could cause precipitation with slow intraneuronal accumulation of huntingtin aggregates. In addition, the activity of transglutaminases has been seen to be increased in 25% of HD patients compared to normal individuals, and it has been proposed that the level of transglutaminase activity affects the age of onset in individuals with equal numbers of CAG repeats (29) . Moreover, a recent study has shown that huntingtin is a substrate of transglutaminase in vitro and that the rate of the reaction increases with length of the polyglutamine (82) . As a result, expanded polyglutamines form polymers.
PROTEINS ASSOCIATED WITH HUNTINGTIN
As mentioned previously, the regional pattern of expression of the IT15 gene cannot explain the selective neuropathology in HD. Therefore, it is possible that medium-sized spiny striatal neurons possess certain properties making them vulnerable to damage induced by expanded polyglutamine. This concept has stimulated a search for huntingtin-associated proteins, which could be selectively expressed in the striatum. While huntingtin is expressed ubiquitously, other proteins that interact with mutated huntingtin may induce toxicity and may be selectively expressed in neurons that die in HD. So far the following proteins have been identified (Table I) : HAP-1 (98), GAPDH (26), HIP-1 (84, 160), HIP-2 (83), and calmodulin (12) .
HAP-1
In 1995, Li and co-workers (98) were the first to identify a protein that binds to huntingtin. The binding is enhanced by an expanded polyglutamine repeat. The protein was termed huntingtin-associated protein (HAP-1). It is enriched in the brain, suggesting a role in the neuropathology of HD. Further studies have focused on the precise localization of HAP-1 in different brain regions. Although HAP-1 is found in the striatum and the cortex, it is also expressed in the accessory olfactory bulb, supraoptic nucleus of hypothalamus, cerebellum, and the pedunculopontine nuclei, regions not affected in HD. These are also the regions where mRNA coding for nNOS is enriched (99) . HAP-1 and nNOS are both enriched in subcellular fractions containing synaptic vesicles, and immunohistochemical studies indicate that in some cases they are the colocalized to the same neurons. Within the human striatum, there seems to be a heterogenous distribution of HAP-1 (54) . HAP-1 is found in both spiny and aspiny neurons, but not in glial cells. In the matrix compartment, a higher content of HAP-1 is seen in neurons which die first in advanced HD. Both huntingtin and HAP-1 are transported in both anterograde and retrograde directions in neurons and are therefore thought to be associated to vesicular membrane trafficking (21) . In support of this theory, HAP-1 binds to a neuronal protein called Duo, a factor specific for Rac1 (33) involved in regulating the cytoskeleton and vesicle transport (129) . Also, HAP-1 associates to dynactin, enriched in synaptic vesicles in the brain (50) .
GAPDH
Burke and co-workers found in 1996 (26) that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) binds to both normal and mutant huntingtin, with a preferential interaction to cleaved fragments of huntingtin in vitro. Both huntingtin and GAPDH are present in the nucleus as well as in the cytoplasm. Intriguingly, GAPDH also binds to other polyglutamine containing proteins as ataxin 1 in SCA1 (87) , atrophin in DRPLA (26) , and the androgen receptor in SBMA (87), indicating a role in these diseases. GAPDH has an essential function in glycolysis, and, as mentioned earlier, reduced energy production is considered to be involved in the neuronal loss seen in HD. Both HD patients and asymptomatic gene carriers display a decreased glucose uptake in basal ganglia as detected by positronemission tomography (64) . An important animal experimental finding is that intrastriatal administration of the GAPDH inhibitor iodoacetate produces striatal lesions that are attenuated by removal of the corticostriatal input, suggesting an excitotoxic mechanism (108) . Furthermore, striatal murine cultures have been shown to be more sensitive than cortical cultures to cell death induced by the GAPDH inhibitor ␣-monochlorohydrin, with a selective sparing of NADPH diaphorasepositive neurons (144) . The neuronal death could also be inhibited by different caspase inhibitors. In addition to its role in glycolysis, GAPDH also binds to RNA, ATP, actin, and tubulin. A mutation in GAPDH is known to alter endocytosis in chinese hamster ovary cells (130) , and as huntingtin has been suggested to function in vesicle transporting in association to microtubuli, an interaction between GAPDH and mutant huntingtin might alter important cellular transport systems.
HIP-1
Another huntingtin-interacting protein is named HIP-1 and displays sequence similarity to cytoskeletal proteins (160) . Specifically, it shares sequence homology and biochemical properties with Sla2p, a protein essential for the function of the cytoskeleton in the Saccharomyces cerevisiae (84) . The HIP-1 gene is expressed in all tissues assessed, but Western blots have shown that the HIP-1 protein is only detectable in the brain. In mice and humans, the HIP-1 protein levels are higher in the neocortex than neostriatum and cerebellum (84) . Quite contrary to the binding between HAP-1 and huntingtin, the degree of HIP-1 interaction with huntingtin is inversely correlated to the length of the polyglutamine stretch. Since HIP-1 may have a role in the cytoskeleton, it has been suggested that loss of its normal interaction with huntingtin could influence the membrane-cytoskeletal integrity in HD.
HIP-2
A huntingtin-interacting protein (HIP-2) was identified in 1996 and was found to be a ubiquitin-conjugating enzyme (83) . In contrast to HAP-1, there is no correlation between the extent of binding of HIP-2 and the length of the polyglutamine tract in huntingtin. The HIP-2 enzyme is highly expressed in brain, including regions affected in HD. Huntingtin is itself ubiquitinated, and degradation of ubiqutinated proteins may somehow play a role in HD pathogenesis. Notably, there is a report describing ubiquitin-positive neurites in HD (28) , and the huntingtin fragments in the neuronal intranuclear inclusions and dystrophic neurites in HD brains are ubiquitinated (44) .
Calmodulin
Bao and co-workers demonstrated in 1996 (12) that huntingtin can form a complex with calmodulin. This interaction is normally Ca 2ϩ -dependent, but when huntingtin has an expanded polyglutamine, it occurs even in the absence of Ca 2ϩ . Possibly the expanded polyglutamine increases the affinity of huntingtin also for other proteins. The association between mutant huntingtin and calmodulin could suggest a role for excitotoxic mechanisms in HD pathogenesis. Thus, an increase of intracellular Ca 2ϩ after activation of NMDA receptors leads to activation of nNOS by the calmodulin/Ca 2ϩ -regulated phosphatase, calcineurin, and this process may be affected by the binding of huntingtin to calmodulin.
MODELS OF THE PATHOGENESIS OF HUNTINGTON'S DISEASE
The following section attempts to combine different pathogenetic models for HD and to propose a unifying hypothesis that encompasses theories regarding excitotoxic cell death, mitochondrial impairment, defective energy metabolism, oxidative stress, and apoptosis (Fig. 6) . Several outstanding issues remain to be resolved: How does mutant huntingtin cause neuronal death, why are primarily striatal neurons affected while other neurons expressing the same protein pass unscathed, and why does it take many years for the pathology to develop? The solution to these issues is probably dependant on an improved understanding of both the role of normal huntingtin in neurons and of the perturbing effects of mutant huntingtin on the homeostasis of striatal neurons.
Glutamate excitotoxicity mediated via the NMDA receptor leads to disruption of intracellular Ca 2ϩ homeostasis, as described in detail under Excitotoxicity above. As mentioned earlier, one of the late consequences of excitotoxic insults may be the release of cytochrome C and AIF from mitochondria (148, 95, 152) , which promotes apoptosis. A human homologue of the proapoptotic cysteine protease CED-3 is called caspase-3 (apopain, CPP32) (61), and during apoptosis it proteolytically cleaves crucial structural and nuclear proteins, as well as other caspases (119, 152) . Caspase-3 may play a role in HD, since Goldberg and collaborators (61) demonstrated that it specifically cleaves huntingtin and that long polyglutamine sequences make huntingtin more susceptible to caspase-3 cleavage. It is possible that processes that lead to cytochrome C and AIF release from mitochondria and its subsequent activation mediated by calcineurin (7) may also trigger the caspase cascade, ultimately resulting in caspase-3 activation. As already mentioned, calcineurin is activated by the Ca 2ϩ /calmodulin complex, and mutant huntingtin readily interacts with calmodulin (12) . One hypothesis for the pathogenesis of HD is that calmodulin is activated by complex formation with the mutant huntingtin even in the absence of external stimuli, facilitating activation of crucial enzymes, such as caspase-3, leading to apotosis. Furthermore, the cleavage of huntingtin by caspase-3 may be responsible for the huntingtin fragments that form inclusions in the nucleus and in dystrophic neurites of neurons in HD patients (44) and HD transgenic mice (36, 37) . Huntingtin cleavage products could also interact with GAPDH, leading to disruption of glycolysis, as smaller huntingtin products have a greater binding affinity for GAPDH than fulllength huntingtin (26) . Disruption of glycolysis would lead to decreased energy metabolism, leading to further membrane depolarization, release of the Mg 2ϩ block of the NMDA receptor, and increase of intracellular Ca 2ϩ   FIG. 6 . Excitotoxicity, oxidative stress, impaired energy metabolism, and apoptosis may all contribute to cell death induced by mutant huntingtin that slowly accumulates in nucleus.
and initiating the processes mentioned previously, resulting in a vicious circle.
Several studies suggest that huntingtin has a role in vesicle trafficking. Both wild type and mutant huntingtin are associated to endocytic and secretory vesicles (156) . In HD cortical and striatal neurons, huntingtin has been observed in a vesicular body involved in retrograde transport and protein degradation (136) . Several of the proteins that huntingtin interacts with are associated with cytoskeleton and vesicle trafficking (HAP-1 (21), Duo (129), dynactin (50) , GAPDH (130) , and HIP-1 (160)), and it is also known that the interaction between huntingtin and these proteins is dependent on the length of the polyglutamine tract (26, 98, 160) .
Is there support for a mitochondrial defect in HD? As mentioned previously, impaired activity of complexes II, III, and IV in the mitochondrial respiratory chain of striatal neurons has been observed (66) . However, the huntingtin protein has not been seen in mitochondria (43) , and it remains unclear how huntingtin could produce the defective complexes. Since only a fraction of the proteins active in mitochondria are actually produced there (45) , huntingtin may interact with nuclear genes that transcribe proteins involved in the mitochondrial respiratory chain, or in the transcription of mitochondrial DNA.
Why are striatal neurons the primary target in HD? It is an attractive idea that the NMDA receptors in striatal medium spiny neurons contribute, even though there are many other brain regions with NMDA receptors that are not affected in HD. The selective vulnerability could also be due to posttranslational modifications, as proposed by Burke and co-workers (26). Moreover, as described under Neuropathology, in HD, striatal interneurons containing NADPH diaphorase and nNOS are selectively spared in the disease. It is possible that their capacity to produce NO renders them resistant to the disease process. NO has different properties and can be toxic or protective, depending on the redox potential (107) . When NO reacts with O 2 Ϫ it forms the highly reactive radical peroxynitrite and promotes neurotoxicity. Conversely, the ability of NO to downregulate NMDA-receptor activity (107) means that it can reduce the effects of glutamate excitotoxicity. Indeed, this latter mechanism may also contribute to the sparing of nNOS-containing striatal neurons in HD besides their content of high levels of manganese superoxide dismutase, as mentioned previously (62) .
Why does the disease process take so many years to develop and pathology not become apparent until midlife in the majority of HD patients? As suggested above, the expanded polyglutamine may lead to increased cleavage of huntingtin, but initially the rate of this cleavage might be so low that counterbalancing mechanisms retard the vicious circle. Conceivably, huntingtin cleavage products may not exert a true toxic effect before they have accumulated in large amounts over several years. A morphological correlate of this accumulation may be the formation of neuronal intranuclear inclusions as seen in both HD and the transgenic HD model (44, 105) .
Albeit many interesting findings have arisen over the past few years, there still remain many questions to be answered. Undoubtedly their solution will generate novel therapeutic strategies for a disease whose sufferers are in desperate need for a cure.
